VAXIMM will participate in the upcoming events listed below.
Please note that, due to the current coronavirus crisis, many conferences have been canceled or postponed.
Feel free to contact us any time by email at BD@vaximm.com.
AACR Annual Meeting
April 10-15 and May 17-21, 2021, Virtual Event
Europe Neoantigen Summit
April 20-22, 2021, Virtual Event
Dr. Heinz Lubenau, CEO of VAXIMM, will give a company presentation at 12:00 pm CEST on 22 April and participate in the panel discussion “Evaluating Combination Therapies”. The panel will take place at 9:30 am CEST on 22 April.
Alliance for Cancer Gene Therapy Summit 2021
April 29, 2021, Virtual Event
18th CIMT Annual Meeting
May 10-12, 2021, Virtual Event
21st Bio€quity Europe
May 17-19, 2021, Virtual Event
Dr. Heinz Lubenau, CEO of VAXIMM, will give a company presentation.
SACHS FORUM: 7th Annual Immuno-Oncology Innovation Forum
May 18-20, 2021, Virtual Event
Dr. Heinz Lubenau, CEO of VAXIMM, will give a company presentation and participate in the panel discussion “Latest Advances in Cell & Gene Therapies Panel”. The panel will be broadcast live at 12:50 pm on May 19.
He will also take part in the online meeting system.
17th Annual Anglonordic Life Science Conference
May 25-26, 2021, Virtual Event
Dr. Heinz Lubenau, CEO of VAXIMM, will give a company presentation on May 26 during the session “Biotech Investment and Technology Investment Company Presentations” starting at 11:00 am CEST.
American Society of Clinical Oncology Annual Meeting 2021
June 4-8, 2021, Virtual Event
BIO KOREA
June 9-11, 2021, Virtual and Live Event
BIO Digital
June 10-11 & June 14-18, 2021, Virtual Event
Dr. Heinz Lubenau, CEO of VAXIMM, will give a company presentation.
Paris Immuno-Oncology Conference
July 1-2, 2021, Virtual Event